<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39370552</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-3599</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of genetic counseling</Title><ISOAbbreviation>J Genet Couns</ISOAbbreviation></Journal><ArticleTitle>Cancer genetic counseling via telegenetics and telephone: A qualitative study exploring the experience of patients and genetic counselors in an Australian cancer genetics context.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/jgc4.1982</ELocationID><Abstract><AbstractText>The demand for direct-to-patient (DTP) telegenetics (genetics services delivered via videoconferencing) in genetic counseling practice has rapidly increased, particularly since the COVID-19 pandemic. Recent telegenetics literature is mostly quantitative and not in the Australian context. A qualitative interview study was conducted to address this gap. This research investigated the experiences of patients and genetic counselors (GCs), enrolled in a randomized controlled trial, using telegenetics and telephone for cancer genetic counseling appointments. Twenty-eight semi-structured interviews with patients (n = 22) and GCs (n = 6) were conducted following patient randomization to either a telephone or telegenetics genetic counseling appointment. The interviews explored participant's experiences of telegenetics and compared DTP telegenetics with telephone and in-person delivery. Codebook thematic analysis was used to develop topic summaries from the data. Patient and GC participants noted positive experiences of telegenetics; with key benefits reported as reduced travel time, time and cost saving, ease, convenience, efficiency, and comfortability. Technical issues and privacy concerns were highlighted as potential disadvantages of telegenetics. All but one patient felt sufficiently emotionally supported while using telegenetics. Telegenetics has both benefits and limitations; however, generally, this cohort found telegenetics to be a suitable and acceptable mode of delivery for genetic counseling with many advantages over in-person or telephone appointments. Further studies should be conducted to provide evidence for the long-term implementation of telegenetics, regardless of any future COVID-19 pandemic lockdown restrictions.</AbstractText><CopyrightInformation>© 2024 The Author(s). Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Finney</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8714-5568</Identifier><AffiliationInfo><Affiliation>Prince of Wales Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Technology Sydney UTS Graduate School of Health, Ultimo, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fargas</LastName><ForeName>Verna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Technology Sydney UTS Graduate School of Health, Ultimo, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Tina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3680-2350</Identifier><AffiliationInfo><Affiliation>Department of Clinical Genetics, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0280-0883</Identifier><AffiliationInfo><Affiliation>School of Population Health, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakefield</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0001-7704-7067</Identifier><AffiliationInfo><Affiliation>School of Clinical Medicine, UNSW Medicine &amp; Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tucker</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Prince of Wales Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Clinical Medicine, UNSW Medicine &amp; Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turbitt</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6650-9702</Identifier><AffiliationInfo><Affiliation>University of Technology Sydney UTS Graduate School of Health, Ultimo, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6353-944X</Identifier><AffiliationInfo><Affiliation>Prince of Wales Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Clinical Medicine, UNSW Medicine &amp; Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>13/TRC/1-03</GrantID><Agency>Cancer Institute NSW</Agency><Country /></Grant><Grant><GrantID>1143767</GrantID><Agency>National Health and Medical Research Council</Agency><Country /></Grant><Grant><GrantID>2008300</GrantID><Agency>National Health and Medical Research Council</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Genet Couns</MedlineTA><NlmUniqueID>9206865</NlmUniqueID><ISSNLinking>1059-7700</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">communication</Keyword><Keyword MajorTopicYN="N">genetic counseling cancer genetics</Keyword><Keyword MajorTopicYN="N">telegenetics</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword><Keyword MajorTopicYN="N">telephone</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370552</ArticleId><ArticleId IdType="doi">10.1002/jgc4.1982</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Australian Bureau of Statistics. (2021). Household impacts of COVID‐19 survey. ABS. https://www.abs.gov.au/statistics/people/people‐and‐communities/household‐impacts‐covid‐19‐survey/apr‐2021</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare. (2019). Cancer in Australia 2019. (cancer series no. 119). AIHW: Australian Institute of Health and Welfare. https://doi.org/10.25816/ye05‐nm50, https://www.aihw.gov.au/getmedia/8c9fcf52‐0055‐41a0‐96d9‐f81b0feb98cf/aihw‐can‐123.pdf.aspx?inline=true</Citation></Reference><Reference><Citation>Bernard, H. R. (2002). Research methods in anthropology: Qualitative and quantitative approaches (3rd ed.). AltaMira Press.</Citation></Reference><Reference><Citation>Boothe, E., &amp; Kaplan, J. (2018). Using telemedicine in Mississippi to improve patient access to genetic services. Journal of Genetic Counseling, 27(2), 320–322. https://doi.org/10.1007/s10897‐017‐0192‐6</Citation></Reference><Reference><Citation>Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and code development. Sage Publications.</Citation></Reference><Reference><Citation>Bradbury, A., Patrick‐Miller, L., Harris, D., Stevens, E., Egleston, B., Smith, K., Mueller, R., Brandt, A., Stopfer, J., Rauch, S., Forman, A., Kim, R., Fetzer, D., Fleisher, L., Daly, M., &amp; Domchek, S. (2016). Utilizing remote real‐time videoconferencing to expand access to cancer genetic services in community practices: A multicenter feasibility study. Journal of Medical Internet Research, 18(2), e23. https://doi.org/10.2196/jmir.4564</Citation></Reference><Reference><Citation>Braun, V., &amp; Clarke, V. (2022). Conceptual and design thinking for thematic analysis. Qualitative Psychology, 9(1), 3. https://doi.org/10.1037/qup0000196</Citation></Reference><Reference><Citation>Breen, K. E., Tuman, M., Bertelsen, C. E., Sheehan, M., Wylie, D., Fleischut, M. H., Offit, K., Stadler, Z. K., Salo‐Mullen, E. E., &amp; Hamilton, J. G. (2022). Factors influencing patient preferences for telehealth cancer genetic counseling during the COVID‐19 pandemic. JCO Oncology Practice, 18(4), 462–471. https://doi.org/10.1200/OP.21.00301</Citation></Reference><Reference><Citation>Brown, E. G., Watts, I., Beales, E. R., Maudhoo, A., Hayward, J., Sheridan, E., &amp; Rafi, I. (2021). Videoconferencing to deliver genetics services: A systematic review of telegenetics in light of the COVID‐19 pandemic. Genetics in Medicine, 23(8), 1438–1449. https://doi.org/10.1038/s41436‐021‐01149‐2</Citation></Reference><Reference><Citation>Buchanan, A. H., Datta, S. K., Skinner, C. S., Hollowell, G. P., Beresford, H. F., Freeland, T., Rogers, B., Boling, J., Marcom, P. K., &amp; Adams, M. B. (2015). Randomized trial of telegenetics vs. in‐person cancer genetic counseling: Cost, patient satisfaction and attendance. Journal of Genetic Counseling, 24(6), 961–970. https://doi.org/10.1007/s10897‐015‐9836‐6</Citation></Reference><Reference><Citation>Castleberry, A., &amp; Nolen, A. (2018). Thematic analysis of qualitative research data: Is it as easy as it sounds? Currents in Pharmacy Teaching &amp; Learning, 10(6), 807–815. https://doi.org/10.1016/j.cptl.2018.03.019</Citation></Reference><Reference><Citation>Clarke, V., &amp; Braun, V. (2021). Thematic analysis: A practical guide (1st ed.). Sage Publications. https://www.vlebooks.com/vleweb/product/openreader?id=none&amp;isbn=9781526417299</Citation></Reference><Reference><Citation>Clay‐Williams, R., Baysari, M., Taylor, N., Zalitis, D., Georgiou, A., Robinson, M., Braithwaite, J., &amp; Westbrook, J. (2017). Service provider perceptions of transitioning from audio to video capability in a telehealth system: A qualitative evaluation. BMC Health Services Research, 17(1), 1–8. https://doi.org/10.1186/s12913‐017‐2514‐7</Citation></Reference><Reference><Citation>Coelho, J. J., Arnold, A., Nayler, J., Tischkowitz, M., &amp; MacKay, J. (2005). An assessment of the efficacy of cancer genetic counselling using real‐time videoconferencing technology (telemedicine) compared to face‐to‐face consultations. European Journal of Cancer, 41(15), 2257–2261. https://doi.org/10.1016/j.ejca.2005.06.020</Citation></Reference><Reference><Citation>Cohen, S. A., Gustafson, S. L., Marvin, M. L., Riley, B. D., Uhlmann, W. R., Liebers, S. B., &amp; Rousseau, J. A. (2012). Report from the national society of genetic counselors service delivery model task force: A proposal to define models, components, and modes of referral. Journal of Genetic Counseling, 21(5), 645–651. https://doi.org/10.1007/s10897‐012‐9505‐y</Citation></Reference><Reference><Citation>Cohen, S. A., Huziak, R. C., Gustafson, S., &amp; Grubs, R. E. (2016). Analysis of advantages, limitations, and barriers of genetic counseling service delivery models. Journal of Genetic Counseling, 25(5), 1010–1018. https://doi.org/10.1007/s10897‐016‐9932‐2</Citation></Reference><Reference><Citation>Danylchuk, N. R., Cook, L., Shane‐Carson, K. P., Cacioppo, C. N., Hardy, M. W., Nusbaum, R., Steelman, S. C., &amp; Malinowski, J. (2021). Telehealth for genetic counseling: A systematic evidence review. Journal of Genetic Counseling, 30(5), 1361–1378. https://doi.org/10.1002/jgc4.1481</Citation></Reference><Reference><Citation>Diaz, V., &amp; Player, M. (2020). Direct‐to‐patient telehealth: Opportunities and challenges. Medicine and Health, Rhode Island, 103(1), 35–37.</Citation></Reference><Reference><Citation>Dörnyei, Z. (2007). Research methods in applied linguistics. Oxford University Press.</Citation></Reference><Reference><Citation>Dratch, L., Paul, R. A., Baldwin, A., Brzozowski, M., Gonzalez‐Alegre, P., Tropea, T. F., Raper, A., &amp; Bardakjian, T. (2021). Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology. Journal of Genetic Counseling, 30(4), 974–983. https://doi.org/10.1002/jgc4.1470</Citation></Reference><Reference><Citation>Gonzalez, T., Tucker, K., Wakefield, C. E., Geelan‐Small, P., Macmillan, S., Taylor, N., &amp; Williams, R. (2022). Comparing cancer genetic counselling using telegenetics with in‐person and telephone appointments: Results of a partially randomised patient‐preference pilot study. Journal of Telemedicine and Telecare, 30(6), 949–960. https://doi.org/10.1177/1357633X221112556</Citation></Reference><Reference><Citation>Gorrie, A., Gold, J., Cameron, C., Krause, M., &amp; Kincaid, H. (2021). Benefits and limitations of telegenetics: A literature review. Journal of Genetic Counseling, 30(4), 924–937. https://doi.org/10.1002/jgc4.1418</Citation></Reference><Reference><Citation>Green, J., &amp; Thorogood, N. (2004). Qualitative methods for health research. SAGE Publications.</Citation></Reference><Reference><Citation>Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., &amp; Wiesner, G. L. (2015). A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral indications for cancer predisposition assessment. Genetics in Medicine, 17(1), 70–87. https://doi.org/10.1038/gim.2014.147</Citation></Reference><Reference><Citation>Hilgart, J. S., Hayward, J. A., Coles, B., &amp; Iredale, R. (2012). Telegenetics: A systematic review of telemedicine in genetics services. Genetics in Medicine, 14(9), 765–776. https://doi.org/10.1038/gim.2012.40</Citation></Reference><Reference><Citation>Kessler, R., Andrews, G., Colpe, L., Hiripi, E., Mroczek, D., Normand, S., Walters, E., &amp; Zaslavsky, A. (2002). Short screening scales to monitor population prevalences and trends in non‐specific psychological distress. Psychological Medicine, 32(6), 959–976. https://doi.org/10.1017/S0033291702006074</Citation></Reference><Reference><Citation>Krueger, C. A., Mont, M. A., Backstein, D. J., Browne, J. A., Krebs, V. E., Mason, J. B., Taunton, M. J., &amp; Callaghan, J. J. (2021). COVID will end but telemedicine may be here to stay. The Journal of Arthroplasty, 36(3), 789–790. https://doi.org/10.1016/j.arth.2021.01.034</Citation></Reference><Reference><Citation>Kubendran, S., Sivamurthy, S., &amp; Schaefer, G. B. (2017). A novel approach in pediatric telegenetic services: Geneticist, pediatrician and genetic counselor team. Genetics in Medicine, 19(11), 1260–1267. https://doi.org/10.1038/gim.2017.45</Citation></Reference><Reference><Citation>Ma, D., Ahimaz, P. R., Mirocha, J. M., Cook, L., Giordano, J. L., Mohan, P., &amp; Cohen, S. A. (2021). Clinical genetic counselor experience in the adoption of telehealth in the United States and Canada during the COVID‐19 pandemic. Journal of Genetic Counseling, 30(5), 1214–1223. https://doi.org/10.1002/jgc4.1516</Citation></Reference><Reference><Citation>Mette, L. A., Saldívar, A. M. P., Poullard, N. E., Torres, I. C., Seth, S. G., Pollock, B. H., &amp; Tomlinson, G. E. (2016). Reaching high‐risk underserved individuals for cancer genetic counseling by video‐teleconferencing. The Journal of Community and Supportive Oncology, 14(4), 162–168. https://doi.org/10.12788/jcso.0247</Citation></Reference><Reference><Citation>Mills, R., MacFarlane, I. M., Caleshu, C., Ringler, M. A., &amp; Zierhut, H. A. (2021). Genetic counselor experiences with telehealth before and after COVID‐19. Journal of Genetic Counseling, 30(4), 999–1009. https://doi.org/10.1002/jgc4.1465</Citation></Reference><Reference><Citation>Morris, Z. S., Wooding, S., &amp; Grant, J. (2011). The answer is 17 years, what is the question: Understanding time lags in translational research. Journal of the Royal Society of Medicine, 104(12), 510–520. https://doi.org/10.1258/jrsm.2011.110180</Citation></Reference><Reference><Citation>Murphy, A., Kirby, A., Lawlor, A., Drummond, F. J., &amp; Heavin, C. (2022). Mitigating the impact of the COVID‐19 pandemic on adult cancer patients through telehealth adoption: A systematic review. Sensors, 22(9), 3598. https://doi.org/10.3390/s22093598</Citation></Reference><Reference><Citation>Otten, E., Birnie, E., Ranchor, A. V., &amp; Van Langen, I. M. (2016). Telegenetics use in presymptomatic genetic counselling: Patient evaluations on satisfaction and quality of care. European Journal of Human Genetics, 24(4), 513–520. https://doi.org/10.1038/ejhg.2015.164</Citation></Reference><Reference><Citation>Pagliazzi, A., Mancano, G., Forzano, G., Giovanni, F., Gori, G., Traficante, G., Iolascon, A., &amp; Giglio, S. (2020). Genetic counseling during COVID‐19 pandemic: Tuscany experience. Molecular Genetics &amp; Genomic Medicine, 8(10), 1433. https://doi.org/10.1002/mgg3.1433</Citation></Reference><Reference><Citation>Pestoff, R., Johansson, P., Nilsen, P., &amp; Gunnarsson, C. (2019). Factors influencing use of telegenetic counseling: Perceptions of health care professionals in Sweden. Journal of Community Genetics, 10(3), 407–415. https://doi.org/10.1007/s12687‐018‐00404‐5</Citation></Reference><Reference><Citation>Pestoff, R., Johansson, P., Danielsson, H., Neher, M., &amp; Gunnarsson, C. (2022). Rapid implementation of telegenetic counseling in the COVID‐19 and Swedish healthcare context: A feasibility study. Frontiers in Health Services, 2, 848512. https://doi.org/10.3389/frhs.2022.848512</Citation></Reference><Reference><Citation>Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., &amp; Williams, J. L. (2006). A new definition of genetic counseling: National Society of Genetic Counselors' task force report. Journal of Genetic Counseling, 15(2), 77–83. https://doi.org/10.1007/s10897‐005‐9014‐3</Citation></Reference><Reference><Citation>Sim, J., Shaw, T., Li, S., Courtney, E., Yuen, J., Chiang, J., Nazir, M., Tan, R., &amp; Ngeow, J. (2021). Understanding patients' views and willingness toward the use of telehealth in a cancer genetics service in Asia. Journal of Genetic Counseling, 30(6), 1658–1670. https://doi.org/10.1002/jgc4.1432</Citation></Reference><Reference><Citation>Skirton, H., Cordier, C., Ingvoldstad, C., Taris, N., &amp; Benjamin, C. (2015). The role of the genetic counsellor: A systematic review of research evidence. European Journal of Human Genetics, 23(4), 452–458. https://doi.org/10.1038/ejhg.2014.116</Citation></Reference><Reference><Citation>Solomons, N. M., Lamb, A. E., Lucas, F. L., McDonald, E. F., &amp; Miesfeldt, S. (2018). Examination of the patient‐focused impact of cancer telegenetics among a rural population: Comparison with traditional in‐person services. Telemedicine Journal and E‐Health, 24(2), 13–138. https://doi.org/10.1089/tmj.2017.0073</Citation></Reference><Reference><Citation>Terry, A. B., Wylie, A., Raspa, M., Vogel, B., Sanghavi, K., Djurdjinovic, L., Caggana, M., &amp; Bodurtha, J. (2019). Clinical models of telehealth in genetics: A regional telegenetics landscape. Journal of Genetic Counseling, 28(3), 673–691. https://doi.org/10.1002/jgc4.1088</Citation></Reference><Reference><Citation>Thomas, E. E., Taylor, M. L., Ward, E. C., Hwang, R., Cook, R., Ross, J., Webb, C., Harris, M., Hartley, C., Carswell, P., Burns, C. L., &amp; Caffery, L. J. (2022). Beyond forced telehealth adoption: A framework to sustain telehealth among allied health services. Journal of Telemedicine and Telecare, 30, 559–569. https://doi.org/10.1177/1357633X221074499</Citation></Reference><Reference><Citation>Tumulak, M. J. R., Pascua, A. V., Jover, E. J. M., Guerbo, R. J., Canoy, G. M. R., &amp; Laurino, M. Y. (2021). Genetic counseling in the time of COVID‐19: The Philippine experience with telegenetics. Journal of Genetic Counseling, 30(5), 1285–1291. https://doi.org/10.1002/jgc4.1518</Citation></Reference><Reference><Citation>Turchetti, D., Battistuzzi, L., Bertonazzi, B., &amp; Godino, L. (2021). Sudden shift to remote genetic counseling during the COVID‐19 pandemic: Experiences of genetics professionals in Italy. Journal of Genetic Counseling, 30(4), 1024–1037. https://doi.org/10.1002/jgc4.1441</Citation></Reference><Reference><Citation>Vogel, R. I., Niendorf, K., Lee, H., Petzel, S., Lee, H. Y., &amp; Geller, M. A. (2018). A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer. Hereditary Cancer in Clinical Practice, 16(1), 13. https://doi.org/10.1186/s13053‐018‐0095‐z</Citation></Reference><Reference><Citation>Zierhut, H. A., MacFarlane, I. M., Ahmed, Z., &amp; Davies, J. (2018). Genetic counselors' experiences and interest in telegenetics and remote counseling. Journal of Genetic Counseling, 27(2), 329–338. https://doi.org/10.1007/s10897‐017‐0200‐x</Citation></Reference><Reference><Citation>Zilliacus, E. M., Meiser, B., Lobb, E. A., Kelly, P. J., Barlow‐Stewart, K., Kirk, J. A., Spigelman, A. D., Warwick, L. J., &amp; Tucker, K. M. (2011). Are videoconferenced consultations as effective as face‐to‐face consultations for hereditary breast and ovarian cancer genetic counseling? Genetics in Medicine, 13(11), 933–941. https://doi.org/10.1097/GIM.0b013e3182217a19</Citation></Reference><Reference><Citation>Zilliacus, E. M., Meiser, B., Lobb, E. A., Kirk, J., Warwick, L., &amp; Tucker, K. (2010). Women's experience of telehealth cancer genetic counseling. Journal of Genetic Counseling, 19(5), 463–472. https://doi.org/10.1007/s10897‐010‐9301‐5</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>